Warhound Exits Stealth With $200M at $1.2B Valuation to Engineer Military Dogs
The Facts
- Warhound, a startup founded by Colossal Biosciences' Ben Lamm with Anduril's Palmer Luckey as partner, emerged from stealth on Thursday with $200 million in funding. TechCrunch only
- Investors include In-Q-Tel, Sequoia, and 8VC; the round values the company at $1.2 billion. TechCrunch only
- The company says more than 80% of U.S. military working dogs come from Europe and fewer than half are fit for service. TechCrunch only
- Warhound plans to take cell lines from Belgian Malinois and German Shepherds, store them in a biobank, and edit genes to create dogs for bomb detection, searches and other operations. TechCrunch only
- Anduril will supply software and hardware such as sensor-equipped protective vests and goggles for dogs and handlers. TechCrunch only
Dive deeper · 4 more factsShow less
- Lamm said Luckey holds no equity and is only a partner; Colossal owns equity and licenses its technology to Warhound. TechCrunch only
- Colossal-owned Viagen will help clone the dogs. Lamm said the first batch is about to be cloned, expected to be born early next year, and to enter service within two years. TechCrunch only
- Pricing is undetermined; Warhound expects to sell to first responders, the Department of Defense, military service groups and police. Lamm said it has briefed many government groups. TechCrunch only
- Warhound says it is working under the guidance of the American Humane Society to certify its training program. TechCrunch only
Context
Warhound, a new company tied to Colossal Biosciences and Anduril, has launched with $200 million in funding to develop genetically engineered working dogs for U.S. military, law enforcement and emergency response use. The company cites reliance on European breeding supply and low training success rates as the motivation.
According to Lamm, the dogs will be trained like standard military working dogs and managed by whoever buys them. No government approval has been described in the report.
How the Agent Panel Scored This
Independent AI personas each scored importance 1–10; the story's score is a trimmed mean (highest and lowest votes dropped). Vote spread: 0.
| 3 | Global Affairs Analyst | A startup funding round and product plans for genetically engineered military dogs are a niche business story with no government contract, approval, or concrete deployment yet, so its impact is limited. |
| 3 | Science & Tech Analyst | A startup funding round and launch with plans for future gene-edited military dogs is a concrete event but of limited immediate impact, with no product, approval, or peer-reviewed result yet. |
| 3 | Business Analyst | A private startup's $200M funding round and product plans for genetically engineered military dogs are a niche, limited-impact corporate launch with no government contract, regulatory action, or market-moving effect yet. |
| 3 | Policy Expert | A private startup's funding round and product plans are a notable business story, but no enacted law, government contract, or executive action has occurred, and the dogs won't enter service for about two years, so the immediate impact is limited. |
| 3 | News Editor | A startup funding announcement with a concrete $200M raise and plans for future cloned dogs is a niche business story with limited immediate impact, since no dogs exist yet and no government contract or approval has been secured. |
| 3 | Critical Reader | A startup funding round and launch plans with no delivered product, verified outcome, or government contract; the concrete event is a financing and announced intent, so impact is limited for now. |
| 3 | Informed Citizen | A startup funding announcement with plans for future genetically engineered dogs, no current government contract or immediate impact on ordinary people, making it minor news with limited near-term consequence. |